AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36569174 — intervention group
Group type: COMPARATOR
Intervention: Standard regulated treatment for chronic non-communicable diseases
Number of subjects: 193
Study 32129855 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine plus cobicistat-boosted darunavir (2DR)
Number of subjects: 160
Study 32129855 — intervention group
Group type: COMPARATOR
Intervention: Current ART (CAR)
Number of subjects: 160
Study 35647826 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation of calf muscles
Number of subjects: 60
Study 35647826 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 60
Study 35647826 — intervention group
Group type: COMPARATOR
Intervention: Supervised breathing exercises
Number of subjects: 60
Study 34053852 — intervention group
Group type: EXPERIMENTAL
Intervention: Smarter Pregnancy online lifestyle coaching platform
Number of subjects: 262
Study 34053852 — intervention group
Group type: COMPARATOR
Intervention: NHS standard periconceptional advice
Number of subjects: 262
Study 32345358 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidance from a clinical dietitian, individualized nutrition plan, telephone follow-up after 4 and 30 days, package of foods and drinks for nutritional needs, goodie bag with protein-rich drinks.
Number of subjects: 0
Study 32345358 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group).
Number of subjects: 0
Study 34116330 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg, BID, three days a week)
Number of subjects: 90
Study 34116330 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg, BID)
Number of subjects: 90
Study 34116330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 35417905 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric monitoring passport (BMP)
Number of subjects: 124
Study 35417905 — intervention group
Group type: COMPARATOR
Intervention: Existing information sheet 'Metabolic surgery and perioperative care'
Number of subjects: 124
Study 34328776 — intervention group
Group type: EXPERIMENTAL
Intervention: Derandomized measurement procedure using fixed Pauli measurements on quantum states.
Number of subjects: 0
Study 34328776 — intervention group
Group type: COMPARATOR
Intervention: Randomized measurement procedure using random single-qubit measurements.
Number of subjects: 0
Study 32993094 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight Leg Raise test and Bragard test performed in a multiple parallel way
Number of subjects: 864
Study 32993094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test of the Slump test and Dejerine’s triad
Number of subjects: 864
Study 35014615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod (n=35)
Number of subjects: 79
Study 35014615 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=35)
Number of subjects: 79
Study 35014615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pidotimod and placebo)
Number of subjects: 79
Study 33715892 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigil (Gemogenovatucel-T)
Number of subjects: 45
Study 33715892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 32108976 — intervention group
Group type: EXPERIMENTAL
Intervention: I Can PIC
Number of subjects: 263
Study 32108976 — intervention group
Group type: COMPARATOR
Intervention: Control (attention control health insurance worksheet)
Number of subjects: 263
Study 35090540 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90
Study 35090540 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine e-aid Cognitive Behavioral Therapy for Insomnia (TCM-eCBT-I)
Number of subjects: 90
Study 35090540 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with TCM-eCBT-I
Number of subjects: 90
Study 35090540 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 33990151 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelsohn maneuver and swallowing training
Number of subjects: 214
Study 33990151 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education, psychological intervention, and training of the oral muscle group)
Number of subjects: 214
Study 33217717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerie campaign
Number of subjects: 475
Study 33217717 — intervention group
Group type: EXPERIMENTAL
Intervention: Dove campaign
Number of subjects: 475
Study 33217717 — intervention group
Group type: EXPERIMENTAL
Intervention: Victoria's Secret campaign
Number of subjects: 475
Study 33217717 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO documentary
Number of subjects: 475
Study 33217717 — intervention group
Group type: COMPARATOR
Intervention: Control (neutral video clip)
Number of subjects: 475
Study 35617368 — intervention group
Group type: EXPERIMENTAL
Intervention: ZF2001 (1 dose) administered at 28 days after priming, followed by ZF2001 at 5 months (CV/ZF/ZF D0-D28-M5)
Number of subjects: 120
Study 35617368 — intervention group
Group type: EXPERIMENTAL
Intervention: ZF2001 (1 dose) administered at 56 days after priming, followed by ZF2001 at 6 months (CV/ZF/ZF D0-D56-M6)
Number of subjects: 120
Study 35617368 — intervention group
Group type: EXPERIMENTAL
Intervention: CV/ZF (D0-M5)
Number of subjects: 120
Study 35617368 — intervention group
Group type: EXPERIMENTAL
Intervention: CV/ZF (D0-M6)
Number of subjects: 120
Study 35617368 — intervention group
Group type: COMPARATOR
Intervention: TIV (trivalent inactivated influenza vaccine)
Number of subjects: 120
Study 33600441 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Affect (NA) condition
Number of subjects: 126
Study 33600441 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Affect (PA) condition
Number of subjects: 126
Study 33600441 — intervention group
Group type: COMPARATOR
Intervention: No affect change (control) condition
Number of subjects: 126
Study 33111942 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose NGF (1 µg) injections
Number of subjects: 20
Study 33111942 — intervention group
Group type: COMPARATOR
Intervention: Control injections of isotonic saline
Number of subjects: 20
Study 36429962 — intervention group
Group type: EXPERIMENTAL
Intervention: Integral‐CARE Interdisciplinary Program (IP)
Number of subjects: 0
Study 36429962 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32808423 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational support programme (including motivational interviews, reminder messages, and education programmes for parents) over a 6-month period
Number of subjects: 64
Study 32808423 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational support programme
Number of subjects: 64
Study 32808423 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine follow-ups)
Number of subjects: 64
Study 32173046 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatments followed by radical surgery (NTS)
Number of subjects: 90
Study 32173046 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoradiation (CRT)
Number of subjects: 90
Study 32757634 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH)
Number of subjects: 95
Study 32757634 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 95
Study 32757634 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 36310089 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice with 380 mg of nitrate (BR)
Number of subjects: 0
Study 36310089 — intervention group
Group type: COMPARATOR
Intervention: Beetroot juice placebo (PL)
Number of subjects: 0
Study 36311889 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 48
Study 36311889 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 48
Study 35179334 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 144
Study 35179334 — intervention group
Group type: EXPERIMENTAL
Intervention: Square Dance
Number of subjects: 144
Study 35179334 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 144
Study 33197676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping Therapy (CT)
Number of subjects: 21
Study 33197676 — intervention group
Group type: COMPARATOR
Intervention: Vigorous Exercise (VE)
Number of subjects: 21
Study 33197676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping plus Vigorous Exercise (VECT)
Number of subjects: 21
Study 33821768 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC IBU/APAP
Number of subjects: 1477
Study 33821768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1477
Study 32804144 — intervention group
Group type: COMPARATOR
Intervention: MCI Aβ+ individuals
Number of subjects: 261
Study 32804144 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 261
Study 32804144 — intervention group
Group type: COMPARATOR
Intervention: MCI Aβ+ and MCI Aβ- individuals
Number of subjects: 261
Study 36350082 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g prunes per day
Number of subjects: 143
Study 36350082 — intervention group
Group type: EXPERIMENTAL
Intervention: Prune treatments (50 g and 100 g)
Number of subjects: 143
Study 36350082 — intervention group
Group type: EXPERIMENTAL
Intervention: Prunes (50 g and 100 g)
Number of subjects: 143
Study 36350082 — intervention group
Group type: EXPERIMENTAL
Intervention: Prunes
Number of subjects: 143
Study 33475255 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64565111 5.0 mg
Number of subjects: 474
Study 33475255 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64565111 7.4 mg
Number of subjects: 474
Study 33475255 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64565111 10.0 mg
Number of subjects: 474
Study 33475255 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 474
Study 33475255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study 32824958 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher maternal total 25(OH)D concentrations
Number of subjects: 304
Study 32824958 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher maternal free 25(OH)D concentrations
Number of subjects: 304
Study 32824958 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher total 25(OH)D concentrations
Number of subjects: 304
Study 32824958 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher VDBP concentrations
Number of subjects: 304
Study 35410294 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention care (MIC) including ibuprofen, omega‐3‐fatty acid, oral nutritional supplement, weekly physical, psychiatric assessment, nutritional counseling, and complementary and alternative medicine.
Number of subjects: 112
Study 35410294 — intervention group
Group type: COMPARATOR
Intervention: Conventional palliative care (CPC) including basic nutritional counseling and megestrol acetate as needed.
Number of subjects: 112
Study 33468454 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS added to a 2-week camp-based therapy
Number of subjects: 0
Study 33468454 — intervention group
Group type: COMPARATOR
Intervention: Camp-based therapy alone
Number of subjects: 0
Study 32343308 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 μg/ml of sufentanil plus 2.5 μg/ml of DEX (Group D)
Number of subjects: 60
Study 32343308 — intervention group
Group type: COMPARATOR
Intervention: 1 μg/ml of sufentanil (Group S)
Number of subjects: 60
Study 35451378 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion (AM)
Number of subjects: 0
Study 32873496 — intervention group
Group type: EXPERIMENTAL
Intervention: Video conferencing telehealth (n = 30)
Number of subjects: 60
Study 32873496 — intervention group
Group type: COMPARATOR
Intervention: Telephone-only telehealth (n = 30)
Number of subjects: 60
Study 35732348 — intervention group
Group type: EXPERIMENTAL
Intervention: adagloxad simolenin/OBI‐821
Number of subjects: 349
Study 34082019 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 592
Study 34082019 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 592
Study 32170194 — intervention group
Group type: EXPERIMENTAL
Intervention: Male voice alarm
Number of subjects: 188
Study 32170194 — intervention group
Group type: EXPERIMENTAL
Intervention: Female voice alarm
Number of subjects: 188
Study 32170194 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid alarm (low-frequency tone + female voice)
Number of subjects: 188
Study 32170194 — intervention group
Group type: COMPARATOR
Intervention: High-frequency tone alarm
Number of subjects: 188
Study 35904229 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-stable collagen matrix (VCMX)
Number of subjects: 20
Study 35904229 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue grafts (SCTG)
Number of subjects: 20
Study 33522902 — intervention group
Group type: EXPERIMENTAL
Intervention: Client reminder designed based on nudge theory principles (Group A)
Number of subjects: 1496
Study 33522902 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully subsidized screening with nudge theory (Group B)
Number of subjects: 1496
Study 33522902 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nudge theory)
Number of subjects: 1496
Study 32478849 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person navigator intervention
Number of subjects: 1300
Study 32478849 — intervention group
Group type: COMPARATOR
Intervention: Active control (written resources handout)
Number of subjects: 1300
Study 33855207 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of metformin, SGLT2 inhibitor, GLP1 receptor agonist, and basal insulin (step-down approach)
Number of subjects: 22
Study 33855207 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily insulin injections (MDI)
Number of subjects: 22
Study 32846549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional warnings
Number of subjects: 1232
Study 32846549 — intervention group
Group type: EXPERIMENTAL
Intervention: Health logos
Number of subjects: 1232
Study 32846549 — intervention group
Group type: COMPARATOR
Intervention: Control (no information)
Number of subjects: 1232
Study 35101139 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB supplementation (3 grams dissolved in 150 ml of orange juice or water)
Number of subjects: 50
Study 35101139 — intervention group
Group type: COMPARATOR
Intervention: Placebo (150 ml of orange juice or water)
Number of subjects: 50
Study 35101139 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB supplementation
Number of subjects: 50
Study 35101139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33959800 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 71
Study 33959800 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine
Number of subjects: 71
Study 33959800 — intervention group
Group type: COMPARATOR
Intervention: saline control
Number of subjects: 71
Study 32822130 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA)
Number of subjects: 106
Study 32822130 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 106
Study 35107563 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol 0.5 μg
Number of subjects: 58
Study 35107563 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 58
Study 32669672 — intervention group
Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 0
Study 32669672 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 32669672 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 33027534 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced recovery room care for 12–18 hours postoperatively in the post-anaesthesia care unit.
Number of subjects: 120
Study 33027534 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced recovery room care
Number of subjects: 120
Study 33027534 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative ward care (implied control)
Number of subjects: 120
Study 33046475 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training programme using elastic devices (elastic bands and tubes), 12-week intervention, 2 sessions per week
Number of subjects: 50
Study 33046475 — intervention group
Group type: COMPARATOR
Intervention: Health education programme, 12-week intervention, 1 session per week
Number of subjects: 50
Study 616796537 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training and impact loading programme for 8 months
Number of subjects: 0
Study 616796537 — intervention group
Group type: COMPARATOR
Intervention: Machine-based isometric exercise training programme using the bioDensity system for 8 months
Number of subjects: 0
Study 616796537 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training and impact loading programme
Number of subjects: 0
Study 616796537 — intervention group
Group type: COMPARATOR
Intervention: Machine-based isometric exercise training programme using the bioDensity system
Number of subjects: 0
Study 36367983 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 288
Study 36367983 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 288
Study 33896655 — intervention group
Group type: EXPERIMENTAL
Intervention: Comb-Simple model
Number of subjects: 509
Study 33896655 — intervention group
Group type: EXPERIMENTAL
Intervention: Comb-LR model
Number of subjects: 509
Study 33896655 — intervention group
Group type: EXPERIMENTAL
Intervention: Comb-RDT model
Number of subjects: 509
Study 33896655 — intervention group
Group type: COMPARATOR
Intervention: Mini-Cog
Number of subjects: 509
Study 33896655 — intervention group
Group type: COMPARATOR
Intervention: Fototest
Number of subjects: 509
Study 33896655 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step application
Number of subjects: 509
Study 32557643 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic monoclonal antibodies (mAbs)
Number of subjects: 0
Study 32557643 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose pharmacokinetic model
Number of subjects: 0
Study 32557643 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable analysis and/or case control analysis
Number of subjects: 0
Study 36457124 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT
Number of subjects: 40
Study 36457124 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% NaClO
Number of subjects: 40
Study 36457124 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% NaClO + PDT
Number of subjects: 40
Study 36457124 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 40
Study 34759549 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural block with 0.75 mL.kg ‐1 of 0.25% bupivacaine and 1 mcg.kg ‐1 of dexmedetomidine
Number of subjects: 46
Study 34759549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal-iliohypogastric block with 0.25 mL.kg ‐1 of 0.25% bupivacaine and 1 mcg.kg ‐1 of dexmedetomidine
Number of subjects: 46
Study 34759549 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (caudal and IL/IH blocks)
Number of subjects: 46
Study 34759549 — intervention group
Group type: COMPARATOR
Intervention: Caudal block
Number of subjects: 46
Study 34759549 — intervention group
Group type: COMPARATOR
Intervention: IL/IH block
Number of subjects: 46
Study 35293484 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath stacking technique (BS) associated with routine physiotherapy
Number of subjects: 34
Study 35293484 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy only (Control Group)
Number of subjects: 34
Study 32063417 — intervention group
Group type: EXPERIMENTAL
Intervention: Stump Cylinder
Number of subjects: 95
Study 32063417 — intervention group
Group type: COMPARATOR
Intervention: custom mold
Number of subjects: 95
Study 35293256 — intervention group
Group type: EXPERIMENTAL
Intervention: New birthing room with adaptable physical features
Number of subjects: 202
Study 33570787 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm implants alone (Group 1)
Number of subjects: 225
Study 33570787 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mm implants + OSFE (Group 2)
Number of subjects: 225
Study 33570787 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mm implants + OSFE (Group 3)
Number of subjects: 225
Study 33570787 — intervention group
Group type: COMPARATOR
Intervention: 6 mm implants (Group 1)
Number of subjects: 225
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: 63 ACE indicators across six domains (maternal mental health problems, maternal substance misuse, adverse family environments, child maltreatment, maternal IPV, high-risk presentations of child maltreatment)
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: 63 ACE indicators
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal mental health problems
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse family environments
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk presentations of child maltreatment
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal substance misuse
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: Any child maltreatment
Number of subjects: 211393
Study 35595677 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal IPV
Number of subjects: 211393
Study 35590301 — intervention group
Group type: EXPERIMENTAL
Intervention: High caries group (≥ 5 decayed surfaces)
Number of subjects: 50
Study 35590301 — intervention group
Group type: COMPARATOR
Intervention: Caries group (2-4 decayed surfaces)
Number of subjects: 50
Study 35590301 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 34535520 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid pain medications
Number of subjects: 0
Study 34535520 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-opioid pain medications
Number of subjects: 0
Study 34535520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain prescriptions
Number of subjects: 0